Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf(Immatics Biotechnologies (Germany)), Sabrina Kuttruff-Coqui(Immatics Biotechnologies (Germany)), Katrin Frenzel(BioNTech (Germany)), Valesca Bukur(BioNTech (Germany)), Stefan Stevanović(German Cancer Research Center), Cécile Gouttefangeas(German Cancer Research Center), Michael Platten(University Hospital Heidelberg), Ghazaleh Tabatabai(University Children's Hospital Tübingen), Valérie Dutoit(University Hospital of Geneva), Sjoerd H. van der Burg(Leiden University Medical Center), Per thor Straten(University of Copenhagen), Francisco Martínez‐Ricarte(Vall d'Hebron Hospital Universitari), Berta Ponsati, Hideho Okada(University of California, San Francisco), Ulrik Lassen(Rigshospitalet), Arie Admon(Technion – Israel Institute of Technology), Christian H. Ottensmeier(University of Southampton), Alexander Ulges(Immatics Biotechnologies (Germany)), Sebastian Kreiter(BioNTech (Germany)), Andreas von Deimling(Heidelberg University), Marco Skardelly(University Children's Hospital Tübingen), Denis Migliorini(University Hospital of Geneva), Judith R. Kroep(Leiden University Medical Center), Manja Idorn(University of Copenhagen), Jordi Rodón(The University of Texas MD Anderson Cancer Center), Jordi Piró, Hans Skovgaard Poulsen(Rigshospitalet), Bracha Shraibman(Technion – Israel Institute of Technology), Katy J. McCann(University of Southampton), Regina Mendrzyk(Immatics Biotechnologies (Germany)), Martin Löwer(BioNTech (Germany)), Monika Stieglbauer(University of Tübingen), Cedrik M. Britten(GlaxoSmithKline (United Kingdom)), David Capper(Charité - Universitätsmedizin Berlin), Marij J.P. Welters(Leiden University Medical Center), Juan Sahuquillo(Vall d'Hebron Hospital Universitari), Katharina Kiesel(Immatics Biotechnologies (Germany)), Evelyna Derhovanessian(BioNTech (Germany)), Elisa Rusch(University of Tübingen), Lukas Bunse(Heidelberg University), Colette Song(Immatics Biotechnologies (Germany)), Sandra Heesch(BioNTech (Germany)), Claudia Wagner(Immatics Biotechnologies (Germany)), Alexandra Kemmer-Brück(BioNTech (Germany)), Jörg Ludwig(Immatics Biotechnologies (Germany)), John C. Castle(BioNTech (Germany)), Oliver Schoor(Immatics Biotechnologies (Germany)), Arbel D. Tadmor(Johannes Gutenberg University Mainz), Edward Green(University Hospital Heidelberg), Jens Fritsche(Immatics Biotechnologies (Germany)), Miriam Meyer(Immatics Biotechnologies (Germany)), Nina N. Pawlowski(Immatics Biotechnologies (Germany)), Sonja Dorner(Immatics Biotechnologies (Germany)), Franziska Hoffgaard(Immatics Biotechnologies (Germany)), Bernhard Rössler(Immatics Biotechnologies (Germany)), Dominik Maurer(Immatics Biotechnologies (Germany)), Toni Weinschenk(Immatics Biotechnologies (Germany)), Carsten Reinhardt(Immatics Biotechnologies (Germany)), Christoph Huber(BioNTech (Germany)), Hans-Georg Rammensee(German Cancer Research Center), Harpreet Singh‐Jasuja(Immatics Biotechnologies (Germany)), Uğur Şahin(BioNTech (Germany)), Pierre-Yves Dietrich(University Hospital of Geneva), Wolfgang Wick(Heidelberg University)
Cited by 925Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis